Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 2
9
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Stereoselectivity of iododoxorubicin reduction in various animal species and humans

, , , , &
Pages 115-121 | Received 09 Apr 1992, Accepted 02 Oct 1992, Published online: 22 Sep 2008

References

  • Arcamone F., Lazzati M., Vicario G. P., Zini G. Disposition of 14C-labelled 4′- epidoxorubicin and doxorubicin in the rat. A comparative study. Cancer Chemotherapy and Pharmacology 1984; 12: 157–166
  • Ballinari D., Pezzoni G., Giuliani F. C., Grandi M. Proceedings of the The American Association for Cancer Research 1989; 30: 482
  • Barbieri B., Grandi M., Bordoni T., Cassinelli G., Giuliani F. C. Proceedings of the 5th NCI-EORTC Symposium on New Drugs in Cancer T herapy 1986, Abstract N.9.16, p. BP0448
  • Barbieri B., Giuliani F. C., Bordoni T., Casazza A. M., Geroni C., Bellini O., Suarato A., Gioia B., Penco S., Arcamone F. Chemical and biological characterization of 4′- iodo-4′-deoxy-doxorubicin. Cancer Research 1987; 47: 4001–4006
  • Broggini M., Sommacampagna B., Paolini A., Dolfini E., Donelli M. G. Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits. Cancer Treatment Reports 1986; 70: 697–702
  • Edwards D. M. F., Marrari P., Efthymiopoulos C., Basileo G., Fraier D., Pianezzola E., Strolin Benedetti M. Pharmacokinetics of iododoxorubicin in the rat, dog and monkey. Drug Metabolism and Disposition 1991; 19: 938–945
  • Facchetti I., Vigevani A. Lipophilic character and biological activity of anthracyclines. Pharmacochemistry Library 1987; 10: 138–140
  • Formelli F., Carsana R., Pollini C. Pharmacokinetics of 4′-deoxy-4′-iodo-doxorubicin in plasma and tissues of tumor-bearing mice compared with doxorubicin. Cancer Research 1987; 47: 5401–5406
  • Gianni L., Vigano L., Surbone A., Ballinari D., Casali P., Tarella C., Collins J. M., Bonadonna G. Pharmacology and clinical toxicity of 4′-iodo-4′-deoxy-doxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. Journal of the National Cancer Institute 1990; 82: 469–477
  • Loveless H., Arena E., Feldsted R. L., Bachur N. R. Comparative mammalian metabolism of adriamycin and daunorubicin. Cancer Research 1978; 38: 593–598
  • Mross K., Maessen P., Van Der Vijgh W. J. F., Gall H., Baven E., Pineda H. M. Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. Journal of Clinical Oncology 1988; 6: 517–526
  • Mross K., Langenbuch T., Burk K., Mayer U., Kaplan E., Hossfeld D. K. Phase I study with iodo-doxorubicin. Contributions to Oncology 1989; 37: 64–73
  • Mross K., Mayer U., Hamm K., Burk K., Hossfeld D. K. Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans. European Journal of Clinical Pharmacology 1990a; 39: 507–513
  • Mross K., Mayer U., Langenbuch T., Hamm K., Burk K., Hossfeld D. Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients. European Journal of Cancer 1990b; 26: 1156–1162
  • Oosterbaan M. J. M., Dirks R. J. M., Vree T. B., Van Der Kleijn E. Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites. Pharmaceutical Research 1984; 1: 33–38
  • Robert J., Armand J. P., Huet S., Klink-Alakl M., Regondo G., Hurteloup P. Pharmacokinetics and metabolism of 4′-iodo-4′-deoxy-doxorubicin in humans. Journal of Clinical Oncology 1992; 10: 1183–1190
  • Schott B., Robert J. Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture. Biochemical Pharmacology 1989; 38: 4069–4074
  • Schott B., Vrignaud P., Ries C., Robert J., Londos-Gagliardi D. Cellular pharmacology of 4′-deoxy-4′-iododoxorubicin. British Journal Cancer 1990; 61: 543–547
  • Speth P. A. J., Minderman H., Haanen C. Idarubicin vs daunorubicin: preclinical and clinical pharmacokinetic studies. Seminars in Oncology 1989; 16: 2–9
  • Strolin Benedetti M., Efthymiopoulos C. Chemioterapici antitumorali. Proceedings of the Meeting Convegno Nazionale di Farmacocinetica. Aspetti Teorici e Pratici Siena. Stampa Grafica Salvi, Perugia May, 1991; 113–137; 27–30; 1990
  • Strolin Benedetti M., Pianezzola E., Fraier D., Castelli M. G., Dostert P. Stereoselectivity of idarubicin reduction in various animal species and humans. Xenobiotica 1991; 21: 473–480
  • Zini G., Vicario G. P., Lazzati M., Arcamone F. Disposition and metabolism of [14-14C]4-demethoxidaunorubicin HCI (idarubicin) and [14-14C]daunorubicin HCI in the rat. Cancer Chemotherapy and Pharmacology 1986; 16: 107–115

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.